Visit our COVID-19 and Preeclampsia resource page. Click Here


We've invested over 1.3 million dollars in preeclampsia research

Last Updated on April 02, 2021


Peter Joseph Pappas Research Grant Program

March 30, 2021 - The 2021 funding season has closed and awardees have been announced. The call for 2022 Letters of Intent announced this summer see full schedule in the Read more section below. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year.

Read more about the Peter Joseph Pappas Research Grant Program.

Questions? Contact 

You can read about our 2021 awardees here

You can read about our 2020 awardees here and this year's full announcement here.

The Vision Grant Award Program

The Preeclampsia Foundation is temporarily suspending its Vision Grant Program for the 2020 season, as a result of the research challenges posed by the COVID-19 outbreak.  Our preeclampsia community remains dedicated to catalyzing much-needed preeclampsia research, and we will keep you updated with new vision grant announcements as we navigate these difficult times.  Please take care of those you hold most dear, and thank you for making the work of the Preeclampsia Foundation possible. 

Questions? Contact 

The EMPOWER Program

EMPOWER (EMpowering Progress in Obstetric and Women's hEalth Research) was established to create partnerships between mentors and single sites or groups within low- and middle-income countries to improve clinical and health services research into the hypertensive disorders of pregnancy.

When available, funding is for a two-year research project. The immediate objective is the completion of a project designed by a local investigator and, when appropriate, the dissemination of the results of the study to change practice and improve care.

EMPOWER is a collaboration of the International Society for the Study of Hypertension in Pregnancy, the Preeclampsia Foundation, PRE-EMPT/Global Pregnancy Collaboration, and supporting organization New Zealand Action on Pre-eclampsia.

Please note: The EMPOWER program is currently on hold and no applications are being accepted at this time.


EMPOWER Program Announces 2016 Recipient

The Preeclampsia Foundation, along with its partners International Society for the Study of Hypertension in Pregnancy (ISSHP) and the PRE-EMPT/Global Pregnancy Collaboration (CoLab), announced the recipient of their EMPOWER Award for preeclampsia-related research at the opening ceremonies of the World Congress of ISSHP. Dr. Sarah Manyame, a physician-researcher with the Department of Obstetrics and Gynaecology at the University of Zimbabwe Parirenvatwa Group of Hospitals, was awarded $60,000 USD for her two-year project “Urine Biomarkers for Preeclampsia in High Risk Women.” Dr. James Roberts with the Magee-Womens Research Institute in Pittsburgh, Pennsylvania, will serve as Dr. Manyame’s mentor.

Questions? Contact


More Information

  • Read final reports from our funded investigators, as well as the published results of our research, here.
  • Sign up to receive immediate announcements about research funding and our monthly Research Roundup, here.

Related Articles